Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 28-09-2016 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Sale of Aspen Pharmacare Remaining Stake | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May advised GlaxoSmithKline plc on the sale of its remaining 6.2% stake in Aspen Pharmacare Holdings Ltd which was announced on 28 September 2016. The disposal was effected by way of an accelerated bookbuilt offering and raised gross proceeds equivalent to GBP477 million.
|
||
| Financial Center: | London | Value: | 500.01-1000.00 |
| Advised Party: | Vendor | Law Firm | Slaughter and May |
| Target Company Jurisdiction: | United States | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Public Company - Recommended Offer |
Lawyer | David Johnson |
